Filing Details
- Accession Number:
- 0001615774-15-001285
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-28 17:20:12
- Reporting Period:
- 2015-05-26
- Filing Date:
- 2015-05-28
- Accepted Time:
- 2015-05-28 17:20:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1266806 | Second Sight Medical Products Inc | EYES | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1625186 | Juliette Anne-Marie Ripley | 12744 San Fernando Road, Bldg. 3 Sylmar CA 91342 | Vp Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-26 | 8,716 | $4.75 | 8,716 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-26 | 8,716 | $13.03 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-05-27 | 11,284 | $4.75 | 11,284 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-27 | 11,284 | $13.04 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-05-27 | 25,629 | $4.75 | 25,629 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-27 | 25,629 | $13.04 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option | Acquisiton | 2015-05-26 | 8,716 | $0.00 | 8,716 | $4.75 |
| Common Stock | Option | Acquisiton | 2015-05-27 | 11,284 | $0.00 | 11,284 | $4.75 |
| Common Stock | Option | Acquisiton | 2015-05-27 | 25,629 | $0.00 | 25,629 | $4.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 124,410 | 2015-09-01 | No | 4 | M | Direct | |
| 113,126 | 2015-09-01 | No | 4 | M | Direct | |
| 87,497 | 2015-09-01 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Option | $4.75 | 2015-09-01 | 4,371 | 87,497 | Direct | |
| Common Stock | Option | $4.75 | 2016-01-01 | 2,500 | 87,497 | Direct | |
| Common Stock | Option | $5.00 | 2017-01-01 | 6,125 | 87,497 | Direct | |
| Common Stock | Option | $5.00 | 2018-04-01 | 4,750 | 87,497 | Direct | |
| Common Stock | Option | $5.00 | 2018-11-01 | 25,000 | 87,497 | Direct | |
| Common Stock | Option | $5.00 | 2019-02-01 | 6,750 | 87,497 | Direct | |
| Common Stock | Option | $5.00 | 2020-02-01 | 10,125 | 87,497 | Direct | |
| Common Stock | Option | $5.00 | 2020-02-01 | 10,625 | 87,497 | Direct | |
| Common Stock | Option | $5.00 | 2021-03-01 | 8,313 | 87,497 | Direct | |
| Common Stock | Option | $5.00 | 2022-03-01 | 5,813 | 87,497 | Direct | |
| Common Stock | Option | $5.00 | 2024-04-01 | 5,813 | 87,497 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2015-09-01 | 4,371 | 87,497 | Direct |
| 2016-01-01 | 2,500 | 87,497 | Direct |
| 2017-01-01 | 6,125 | 87,497 | Direct |
| 2018-04-01 | 4,750 | 87,497 | Direct |
| 2018-11-01 | 25,000 | 87,497 | Direct |
| 2019-02-01 | 6,750 | 87,497 | Direct |
| 2020-02-01 | 10,125 | 87,497 | Direct |
| 2020-02-01 | 10,625 | 87,497 | Direct |
| 2021-03-01 | 8,313 | 87,497 | Direct |
| 2022-03-01 | 5,813 | 87,497 | Direct |
| 2024-04-01 | 5,813 | 87,497 | Direct |
Footnotes
- Ms. Ripley aquired 45,629 shares on exercise of options (which expire on September 1, 2015) reported as Option(1) on Form 3 filed with the SEC on November 18, 2014 and sold those shares as reported in Table I.
- These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter.
- These are vested employee options currently exercisable.
Billionaire Hedge Funds
